Streptococcus Vaccines
Data advance knowledge in streptococcus vaccines research
Published in Immunotherapy Weekly, May 18th, 2005
Study 1: The FAI protein of group C streptococci targets B-cells and exhibits adjuvant activity.
"We have demonstrated that the fibrinogen-albumin-IgG receptor of group C streptococci (FAI) targets B-cells in vivo. We exploited the targeting properties of FAI to improve the immune responses stimulated by soluble antigens administered by the mucosal route. Enhanced systemic and mucosal immune responses were observed in mice after intranasal immunization when ovalbumin was fused to FAI or truncated derivatives," scientists writing in the journal...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
Source: Immunotherapy Weekly (2005-05-18)
More Articles from Immunotherapy Weekly
- Arthritis
Antigen-specific B cells needed to induce severe autoimmune arthritis - Arthritis
TNF-alpha-308 promoter polymorphism contributed to rheumatoid arthritis severity - Carcinogenesis
Immunopropylactic approaches against chemical carcinogenesis reviewed - Diabetes Therapy
RSK4, PAK5: Potential treatment targets for diabetic nephro- and neuropathy - Vaccine Vector
Avipoxvirus multiplication in mammalian cell line reported - Acute Lymphoblastic Leukemia
RAS mutation associated with hyperdiploidy/parental characteristics in ALL - More from this issue of Immunotherapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
